or
forgot password
  • cancer clinical trials in ann arbor, MI

  • Sarcoma Study of MORAb-004 Utilization: Research and Clinical Evaluation.
    University of Michigan Health System
    Ann Arbor, Michigan
    Metastatic Soft Tissue Sarcoma
    Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery
    Saint Joseph Mercy Hospital

    Trial Locations
    Saint Joseph Mercy Hospital
    Michigan Cancer Research Consortium Community Clinical Oncology Program
    University of Michigan University Hospital
    Clear Cell Renal Cell Carcinoma, Stage IV Renal Cell Cancer
    Evaluation of Metformin, Targeting Cancer Stem Cells for Prevention of Relapse in GYN Patients
    University of Michigan
    Ann Arbor, Michigan 48109-0624
    Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
    An Open-label, Multi-center, Expanded Access Study of Pasireotide s.c. in Patients With Cushing's Disease
    University of Michigan Medical Center
    Ann Arbor, Michigan 48104-0914
    Cushing's Disease
    Neuroblastoma Biology Study
    C.S Mott Children's Hospital
    Ann Arbor, Michigan 48109
    Neuroblastoma
    Developing an In-vitro Diagnostic Risk-Stratification Test for Oral Cancer
    University of Michigan
    Ann Arbor, Michigan 48109-0624
    Oral Squamous Cell Cancer
    ch14.18 Pharmacokinetic Study in High-risk Neuroblastoma
    University of Michigan C.S. Mott Children's Hospital
    Ann Arbor, Michigan 48109
    Neuroblastoma
    Safety Study of Anti-Programmed Death-1 in Hematologic Malignancy
    University of Michigan Health System
    Ann Arbor, Michigan
    Non-Hodgkin's Lymphoma, Hodgkin Lymphoma, Multiple Myeloma, Chronic Myelogenous Leukemia
    Study of MLN8237 in Combination With Irinotecan and Temozolomide
    University of Michigan Comprehensive Cancer Center
    Ann Arbor, Michigan 48109-0752
    Neuroblastoma
    A Dose Escalation Study of OMP-54F28 in Subjects With Solid Tumors
    University of Michigan Comprehensive Cancer Center
    Ann Arbor, Michigan 48109-0752
    Solid Tumors
    Maribavir for Treatment of Resistant or Refractory CMV Infections in Transplant Recipients
    University of Michigan
    Ann Arbor, Michigan 48109-0624
    Cytomegalovirus Infections
    Sorafenib Tosylate Following a Liver Transplant in Treating Patients With Liver Cancer
    University of Michigan University Hospital
    Ann Arbor, Michigan 48109
    Adult Primary Hepatocellular Carcinoma, Localized Resectable Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer, Recurrent Adult Primary Liver Cancer
    A In-Vivo Esophageal Protocol for Detection of Neoplasia in the Digestive Tract
    University of Michigan
    Ann Arbor, Michigan 48109-0624
    Barrett's Esophagus
    Phase Ib of Abiraterone Acetate Plus BEZ235 or BKM120 in Castration-resistant Prostate Cancer (CRPC) Patients
    University of Michigan Comprehensive Cancer Center Dept of Oncology
    Ann Arbor, Michigan 48109-0944
    Castration-resistant Prostate Cancer
    Alisertib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus
    Saint Joseph Mercy Hospital

    Trial Locations
    Saint Joseph Mercy Hospital
    Michigan Cancer Research Consortium Community Clinical Oncology Program
    Recurrent Uterine Sarcoma, Uterine Leiomyosarcoma
    Study of Everolimus Added to Combined Hormonal and Radiation Therapy for High Risk Prostate Cancer
    University of Michigan Comprehensive Cancer Center
    Ann Arbor, Michigan 48109-0752
    Prostate Cancer
    Afatinib Expanded Access Program
    1200.45.053 Boehringer Ingelheim Investigational Site
    Ann Arbor, Michigan
    Carcinoma, Non-Small-Cell Lung
    Reduced-intensity Therapy for Advanced Oropharyngeal Cancer in Non-smoking Human Papilloma Virus (HPV)-16 Positive Patients
    University of Michigan Comprehensive Cancer Center
    Ann Arbor, Michigan 48109-0752
    Oropharyngeal Cancer
    Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
    University of Michigan Medical Center, Site #011
    Ann Arbor, Michigan 48109
    Chronic Myeloid Leukemia
    Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer
    University of Michigan
    Ann Arbor, Michigan 48109-0624
    Mucinous Adenocarcinoma of the Colon, Mucinous Adenocarcinoma of the Rectum, Signet Ring Adenocarcinoma of the Colon, Signet Ring Adenocarcinoma of the Rectum, Stage IV Colon Cancer, Stage IV Rectal Cancer
    Pioglitazone in Follicular or Follicular Variant of Papillary Thyroid Cancers
    University of Michigan
    Ann Arbor, Michigan 48109-0624
    Follicular Thyroid Carcinoma, Follicular Variant of Papillary Thyroid Carcinoma
    Multiple Ascending Dose
    University of Michigan
    Ann Arbor, Michigan 48109-0624
    Hepatocellular Carcinoma
    Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With Chemotherapy
    Saint Joseph Mercy Hospital

    Trial Locations
    Saint Joseph Mercy Hospital
    Michigan Cancer Research Consortium Community Clinical Oncology Program
    University of Michigan University Hospital
    Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage IV Pancreatic Cancer
    A Trial of Gemcitabine, Infusional 5-Fluorouracil and Cisplatin for Advanced Pancreatic and Biliary Cancers
    University of Michigan Comprehensive Cancer Center
    Ann Arbor, Michigan 48109-0752
    Pancreatic Cancer, Biliary Cancer
    Study of Everolimus With Bevacizumab to Treat Refractory Malignant Peripheral Nerve Sheath Tumors
    University of Michigan
    Ann Arbor, Michigan 48109-0624
    Malignant Peripheral Nerve Sheath Tumors, MPNST, Sarcoma
    Cross-Sectional Study of Oral Health in Patients After Parotid-Sparing Radiation Therapy for Head and Neck Cancer
    University of Michigan Comprehensive Cancer Center
    Ann Arbor, Michigan 48109-0752
    Head and Neck Cancer
    Reduced-intensity Therapy for Oropharyngeal Cancer in Non-smoking HPV-16 Positive Patients
    University of Michigan Health System
    Ann Arbor, Michigan
    Squamous Cell Carcinoma of the Oropharynx, HPV
    A Trial of Cabozantinib (XL184) and Gemcitabine in Advanced Pancreatic Cancer
    University of Michigan Comprehensive Cancer Center
    Ann Arbor, Michigan 48109-0752
    Pancreatic Cancer
    Clinical Trial Of Neoadjuvant Chemotherapy (NAC)In Upper Tract Urothelial Carcinoma (UTUC)
    University of Michigan
    Ann Arbor, Michigan 48109-0624
    Urothelial Cancer, Bladder Cancer
    Effect of Radiation on Tissue for Delayed Breast Reconstruction
    University of Michigan
    Ann Arbor, Michigan 48109-0624
    Breast Cancer
    Study of BMS-936558 vs. Everolimus in Pre-Treated Advanced Or Metastatic Clear-cell RCC
    University of Michigan Health System
    Ann Arbor, Michigan
    Advanced or Metastatic (Medically or Surgically Unresectable) Clear-cell Renal Cell Carcinoma
    Neratinib in Metastatic HER2 Non-amplified But HER2 Mutant Breast Cancer
    University of Michigan
    Ann Arbor, Michigan 48109-0624
    Breast Neoplasms
    A Study to Assess the Safety, Pharmacokinetics and Effectiveness of AGS-16C3F Monotherapy in Subjects With Renal Cell Carcinoma (RCC) of Clear Cell or Papillary Histology
    University of Michigan Medical Center
    Ann Arbor, Michigan 48104-0914
    Carcinoma, Renal Cell, Renal Cell Carcinoma With Clear Cell Histology, Renal Cell Carcinoma With Non-Clear Cell Histology, Renal Cell Carcinoma of Papillary Histology
    Tivantinib With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Locally Advanced Kidney Cancer That Cannot be Removed by Surgery
    Saint Joseph Mercy Hospital

    Trial Locations
    Saint Joseph Mercy Hospital
    Michigan Cancer Research Consortium Community Clinical Oncology Program
    Childhood Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer, Type 1 Papillary Renal Cell Carcinoma, Type 2 Papillary Renal Cell Carcinoma
    Cetuximab With or Without Tivantinib in Treating Patients With Head and Neck Cancer That Is Recurrent, Metastatic, or Cannot Be Removed By Surgery
    University of Michigan Comprehensive Cancer Center
    Ann Arbor, Michigan 48109-0752
    Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage III Salivary Gland Cancer, Stage III Squamous Cell Carcinoma of the Hypopharynx, Stage III Squamous Cell Carcinoma of the Larynx, Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage III Squamous Cell Carcinoma of the Nasopharynx, Stage III Squamous Cell Carcinoma of the Oropharynx, Stage III Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage III Verrucous Carcinoma of the Larynx, Stage III Verrucous Carcinoma of the Oral Cavity, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IVA Salivary Gland Cancer, Stage IVA Squamous Cell Carcinoma of the Larynx, Stage IVA Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IVA Squamous Cell Carcinoma of the Oropharynx, Stage IVA Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IVA Verrucous Carcinoma of the Larynx, Stage IVA Verrucous Carcinoma of the Oral Cavity, Stage IVB Salivary Gland Cancer, Stage IVB Squamous Cell Carcinoma of the Larynx, Stage IVB Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IVB Squamous Cell Carcinoma of the Oropharynx, Stage IVB Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IVB Verrucous Carcinoma of the Larynx, Stage IVB Verrucous Carcinoma of the Oral Cavity, Stage IVC Salivary Gland Cancer, Stage IVC Squamous Cell Carcinoma of the Larynx, Stage IVC Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IVC Squamous Cell Carcinoma of the Oropharynx, Stage IVC Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IVC Verrucous Carcinoma of the Larynx, Stage IVC Verrucous Carcinoma of the Oral Cavity, Tongue Cancer, Untreated Metastatic Squamous Neck Cancer With Occult Primary
    Characterization of Circulating Tumor Cells (CTC) From Patients With Metastatic Breast Cancer Using the CTC-Endocrine Therapy Index
    University of Michigan Comprehensive Cancer Center
    Ann Arbor, Michigan 48109-0752
    Metastatic Breast Cancer
    Cabozantinib in Treating Younger Patients With Recurrent or Refractory Solid Tumors
    C S Mott Children's Hospital
    Ann Arbor, Michigan 48109
    Recurrent Melanoma, Recurrent Thyroid Cancer, Thyroid Gland Medullary Carcinoma, Unspecified Childhood Solid Tumor, Protocol Specific
    Lenalidomide and Monoclonal Antibody With or Without Isotretinoin in Treating Younger Patients With Refractory or Recurrent Neuroblastoma
    C S Mott Children's Hospital
    Ann Arbor, Michigan 48109
    Disseminated Neuroblastoma, Localized Unresectable Neuroblastoma, Recurrent Neuroblastoma, Regional Neuroblastoma, Stage 4S Neuroblastoma
    A Phase I In-Vivo Peptide Applied in the Right Colon
    University of Michigan
    Ann Arbor, Michigan 48109-0624
    Colon Lesions
    Mastectomy Reconstruction Outcomes Consortium (MROC) Study
    University of Michigan Medical Center

    Trial Locations
    University of Michigan Medical Center
    St. Joseph's Mercy Health System
    Breast Cancer
    Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma
    University of Michigan University Hospital
    Ann Arbor, Michigan 48109
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor
    Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia
    C.S. Mott Children's Hospital
    Ann Arbor, Michigan 48109-0914
    Relapsed Acute Lymphoblastic Leukemia, Relapsed Acute Myelogenous Leukemia
    A Pilot Study of Metformin Therapy in Patients With Relapsed Chronic Lymphocytic Leukemia (CLL) and Untreated CLL
    University of Michigan Comprehensive Cancer Center
    Ann Arbor, Michigan 48109-0752
    Relapsed Chronic Lymphocytic Leukemia
    Choline PET/CT and MRI for Targeted Prostate Biopsy
    University of Michigan Health Systems
    Ann Arbor, Michigan 48109
    Prostate Cancer
    ECHELON-2: A Comparison of Brentuximab Vedotin and CHP With Standard-of-care CHOP in the Treatment of Patients With CD30-positive Mature T-cell Lymphomas
    University of Michigan Comprehensive Cancer Center
    Ann Arbor, Michigan 48109-0752
    Lymphoma, Large-Cell, Anaplastic, Lymphoma, Non-Hodgkin, Lymphoma, T-Cell
    Benefits of Exercise Training in Head and Neck Cancer Patients Undergoing Organ-Preserving Definitive Therapy
    The University of Michigan Comprehensive Cancer Center
    Ann Arbor, Michigan 48109
    Head and Neck Squamous Cell Carcinoma
    A Randomized Control Trial of Sun Protection Interventions for Operating Engineers
    University of Michigan School of Nursing
    Ann Arbor, Michigan 48109
    Skin Cancer Prevention
    Simulated Screening Study for Breast Imaging
    University of Michigan Hospital
    Ann Arbor, Michigan 48109
    Breast Cysts, Breast Abnormalities, Breast Tumors
    S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer
    University of Michigan University Hospital
    Ann Arbor, Michigan 48109
    Prostate Cancer
    Prostate Capsule Sparing Cystectomy and Nerve-sparing Radical Cystoprostatectomy in Men With Bladder Cancer
    University of Michigan
    Ann Arbor, Michigan 48109-0624
    Bladder Cancer, Transitional Cell Carcinoma of the Bladder
    Pilot Trial to Determine Organ Motion Using Active Breathing Control (ABC) in Patients With Pancreatic Cancer
    University of Michigan Comprehensive Cancer Center
    Ann Arbor, Michigan 48109-0752
    Pancreatic Cancer
    Anatomical and Functional Differences Between Continent and Incontinent Men Post Radical Prostatectomy
    University of Michigan

    Trial Locations
    University of Michigan
    VA Ann Arbor Healthcare System
    Prostate Cancer, Post Prostatectomy Incontinence
    Tivantinib in Treating Patients With Previously Treated Malignant Mesothelioma
    University of Michigan University Hospital
    Ann Arbor, Michigan 48109
    Epithelial Mesothelioma, Recurrent Malignant Mesothelioma, Sarcomatous Mesothelioma, Stage II Malignant Mesothelioma, Stage III Malignant Mesothelioma, Stage IV Malignant Mesothelioma